Results 11 to 20 of about 64,677 (273)
Indian Journal of Urology, 2014 With the exclusion of non-melanomatous skin malignancy, prostate cancer (PCa) is the second most prevalent cancer in men globally. It has been reported that the majority of men will develop benign prostatic hyperplasia (BPH) by the time they reach their 60s.
Saiful Miah, James Catto
openaire +4 more sources
Primary BPH Stromal Cell Cultures Exhibit Heightened Androgen‐Responsiveness
The Prostate, EarlyView.Background Benign prostatic hyperplasia (BPH) is the most common disease in aging males. BPH growth is androgen‐dependent, and it appears that androgens preferentially stimulate the growth of BPH as compared to normal prostate.
Zhou Wang +9 more
core +2 more sources
Management of the complications of BPH/BOO
Indian Journal of Urology, 2014 Most men will develop histological BPH if they live long enough. Approximately, half will develop benign prostatic enlargement (BPE) and about half of these will get BOO with high bladder pressures and low flow, this in turn leads to detrusor wall hypertrophy. Many of these men will only have lower urinary tract symptoms (LUTS) but a significant number
Mark J Speakman, Xi Cheng
openaire +4 more sources
Analysis of Notch1 and Notch3 Signaling Pathway Components in Benign Prostatic Hyperplasia and Prostate Cancer Patients. [PDF]
J Clin Lab AnalThis study evaluates the association between Notch1 and Notch3 genetic variations and serum protein levels in patients with benign prostatic hyperplasia and prostate cancer. While genetic variations showed no significant link to disease risk, serum protein levels were significantly lower in prostate cancer and metastatic groups compared to healthy ...
Yagci E +4 more
europepmc +2 more sources
Mutraghata: An Ayurvedic Review w.s.r to BPH [PDF]
, 2022 Lower urinary tract symptoms (LUTS) are quite common in aging males and these affect the quality of life of an individual. Among various etiologies of LUTS, benign hyperplasia (BPH) has a high prevalence.
Rakesh R N, Annet Thomas
core +1 more source
Ultrafast Chemical Pre-Sodiation of Pseudocapacitive CaV<sub>8</sub>O<sub>20</sub> Anodes for High-Performance Sodium-Ion Capacitors. [PDF]
Adv Sci (Weinh)An ultrafast (2‐minute), gas‐free chemical pre‐sodiation strategy using Na‐benzophenone is developed to compensate for initial sodium loss in calcium vanadate (CaV8O20). Driven by the Ca2+ ‘spectator effect’, the framework enables highly reversible, quasi‐zero‐strain solid‐solution sodium storage, explicitly bypassing destructive conversion reactions ...
Bansal N +7 more
europepmc +2 more sources
Interstitial laser therapy of benign prostatic hyperplasia [PDF]
, 1999 The objective of interstitial laser coagulation (ILC) of benign prostatic enlargement is to achieve a marked volume reduction and to decrease bladder outlet obstruction and lower urinary tract symptoms with minimal morbidity.
Muschter, Rolf, Whitfield, Hugh
core +1 more source
How different strains of COVID-19 affect LUTS in BPH patients? [PDF]
Journal of Men's Health, 2023 In late 2019, an outbreak of pneumonia of unknown etiology was reported in Wuhan (China). The causative agent was quickly identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Atanas Ivanov +4 more
doaj +1 more source
Biomedicines, 2022 (1) Background: Practice guidelines define drug-eluting stents (DES) as the standard of care in coronary percutaneous coronary intervention (PCI), including in acute coronary syndrome (ACS).
Frederic C. Daoud +4 more
doaj +1 more source
A novel nomogram using PSA mass for predicting BPH [PDF]
Journal of Men's Health, 2023 In 2019, there were 94 million cases of benign prostatic hyperplasia globally among men aged 40 years and older. Assessment of prostate volume (PV) is important in evaluating lower urinary tract symptoms and risks in asymptomatic individuals.
Hsiang Kai Ho +2 more
doaj +1 more source